FXR deletion in hepatocytes does not affect the severity of alcoholic liver disease in mice
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 50 (10) , 1068-1075
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01GM104037)
- VA grant (BX002741)
- Rutgers Busch grant
This publication has 24 references indexed in Scilit:
- New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseasesWorld Journal of Gastroenterology, 2014
- The FXR agonist 6ECDCA reduces hepatic steatosis and oxidative stress induced by ethanol and low-protein diet in miceChemico-Biological Interactions, 2014
- Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver diseaseBiochemical and Biophysical Research Communications, 2014
- Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in miceHepatology, 2012
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel diseaseGut, 2011
- Activation of the Farnesoid X Receptor Provides Protection against Acetaminophen-Induced Hepatic ToxicityMolecular Endocrinology, 2010
- Suppression of interleukin-6-induced C-reactive protein expression by FXR agonistsBiochemical and Biophysical Research Communications, 2009
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory responseHepatology, 2008
- Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptorProceedings of the National Academy of Sciences of the United States of America, 2006
- II. Alcoholic liver injury involves activation of Kupffer cells by endotoxinAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1998